Genes that control cell death may play a role in age-related hearing loss
October 17th, 2008 - 2:07 pm ICT by ANIWashington, Oct 17 (ANI): A new study in mice has suggested that several genes that play a role in how human body’’s cells normally auto-destruct may play a role in age-related hearing loss.
While more than 100 genes are known to play a role in congenital deafness, scientists have yet to pinpoint any gene in humans that plays a role in presbycusis, or age-related hearing loss.
“It’’s very likely that multiple genes contribute to age-related hearing loss. We know the same is true for other diseases, for instance some types of cancer and heart disease,” said Robert D. Frisina, Ph.D., the lead investigator and professor of Otolaryngology at the University of Rochester Medical Center.
To begin to understand the genetics of human hearing, the group charted the activity of more than 22,000 genes in mice, comparing young mice to their older counterparts.
The team used two different methods to study gene expression. First, scientists put more than 300 genes through a broad gene-array study, looking at genes whose activity in the inner ear differed greatly between normal mice and those with hearing loss.
Then the researchers narrowed its focus to 35 such genes, employing a newer technique known as a PCR array to measure activity.
Through that test the researchers identified eight genes, all part of the apoptotic process, whose activity differed between the two groups.
Apoptosis itself is certainly nothing new. Such programmed cell death happens constantly it’’s the body’’s way of getting rid of cells that are damaged or no longer needed.
When apoptosis happens, a cell’’s structure breaks up, and the cell disintegrates, with the cell “blebbing,” or bulging outward, ultimately blowing apart.
It’’s a familiar process to scientists who know that it also happens as part of the course of many diseases. For instance, after a stroke, many brain cells perceive a threat low oxygen and “jump ship,” killing themselves and dramatically worsening the effects of the stroke.
The new study, which is the first one to show that such activity also occurs in the aging inner ear, offers a potential new target as scientists work to find ways to stop age-related hearing loss, such as a drug that would stop cells from committing cell suicide as they age.
Besides genetics, other factors that play a role in presbycusis include sound exposure, medications that can damage hearing, the condition of the brain as it deteriorates with age, and changes in the delicate cells in the inner ear that translate a sound into a signal that the brain “hears.”
The study is published online in the journal Apoptosis. (ANI)
- Harnessing stem cells to prevent hearing loss - Dec 28, 2011
- Lactate levels in brain help in monitoring aging process - Nov 03, 2010
- Scientists create 'golden ear' mouse with great hearing as it ages - Nov 10, 2009
- Nasal stem cells could tackle childhood hearing problems - Feb 10, 2011
- Gene linked to age-related hearing loss identified - Dec 03, 2008
- New hope for restoring hearing loss in adults - Aug 28, 2010
- New discovery brings anti-ageing pill a step closer - Nov 20, 2010
- Function of novel molecule that underlies human deafness revealed - Jan 22, 2011
- Fasting develops smarter brain, shapelier you - Feb 20, 2012
- Invisible infrared light could soon activate heart, ear cells - Mar 28, 2011
- Gene-silencing that could prevent diabetes-related heart failure - Dec 10, 2010
- Scientists identify gene linked to rare form of progressive hearing loss in males - Dec 18, 2009
- Protein linked to hearing loss in elderly identified - Nov 11, 2009
- Short DNA 'end-caps' linked to diabetes risk - Mar 25, 2011
- Cholesterol regulator plays key role in development of liver fibrosis - Mar 31, 2011
Tags: auto destruct, blebbing, brain cells, counterparts, frisina, gene expression, genes, hearing loss, heart disease, human body, inner ear, jump ship, mice, otolaryngology, presbycusis, programmed cell death, rochester medical center, types of cancer, university of rochester, university of rochester medical center